N-[(3aS,4R,6S,6aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]carbamicacid phenylmethyl ester
![BK41BE | 274693-53-7 | N-[(3aS,4R,6S,6aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]carbamicacid phenylmethyl ester](https://qncdn.chemcd.cn/alchemypharm/AP10623.png "BK41BE | 274693-53-7 | N-[(3aS,4R,6S,6aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]carbamicacid phenylmethyl ester")
Catalog No.: BK41BE
CAS.RN：274693-53-7
Molecular Formula: C16H21NO5
Molecular Weight: 307.34 g/mol
Purity: NLT 98%
Intermediates of Ticagrelor
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA3K20 | Ticagrelor API | 274693-27-5 |
| BK15B7 | 2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid | 376608-65-0 |
| BK0SG8 | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate | 376608-71-8 |
| BK9TV8 | 4,6-dichloro-2-propylthiopyrimidine-5-amine | 145783-15-9 |
| BK47AP | (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride | 1156491-10-9 |
| BK5E5R | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium hydrochloride | 1402222-66-5 |
| BK84WC | Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[[5-amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]- | 376608-74-1 |
| BK41BE | N-[(3aS,4R,6S,6aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]carbamicacid phenylmethyl ester | 274693-53-7 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
